Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based bioph... Read more
Alnylam Pharmaceuticals
50 followers
Omnicell
32 followers
West Pharmaceutical Services
12 followers
Otsuka Pharmaceutical US
4 followers
Incyte
37 followers
Amneal Pharmaceuticals
18 followers
Hovione
6 followers
Bristol-Myers Squibb
317 followers
ACI Limited
76 followers
Viatris
53 followers
NYU Langone Health
50 followers
Jazz Pharmaceuticals
47 followers